Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 6:15:11-17.
doi: 10.2147/OPTH.S282440. eCollection 2021.

Combined Phacoemulsification and 360-Degree Endocyclophotocoagulation with and without a Kahook Dual Blade in Patients with Primary Open-Angle Glaucoma

Affiliations

Combined Phacoemulsification and 360-Degree Endocyclophotocoagulation with and without a Kahook Dual Blade in Patients with Primary Open-Angle Glaucoma

Juan Carlos Izquierdo et al. Clin Ophthalmol. .

Abstract

Purpose: The present study aimed to compare the outcomes of combined phacoemulsification and 360-degree endocyclophotocoagulation with and without goniotomy using a Kahook Dual Blade in patients with glaucoma.

Patients and methods: We enrolled 37 patients, 21 of whom underwent combined phacoemulsification with 360-degree endocyclophotocoagulation and goniotomy using a Kahook Dual Blade (tri-modal therapy (T-MT) group). The remaining 16 patients underwent phacoemulsification with endocyclophotocoagulation (bi-modal therapy (B-MT) group). Visual acuity, intraocular pressure, and number of glaucoma medications were recorded before the study and postoperatively on the first day, at week 1, and at 1, 3, 6, 9, and 12 months. Surgical success was defined as an IOP ≤12 mmHg and ≥6 mmHg or an at least 20% reduction in IOP from baseline with (qualified success) or without medications (complete success).

Results: Forty-nine eyes were included. Baseline mean IOP was 16.96±3.66 mmHg and 15.64±4.88 mmHg in the T-MT and B-MT groups (p=0.122), respectively. At the 12-month follow-up, mean IOP values were 11.44±2.15 mmHg and 12.45±1.90 mmHg (p=0.031) in the T-MT and B-MT groups, respectively. Complete success rates were 37% in the T-MT group and 31% in the B-MT group, while qualified success rates were 74% and 50%, respectively. Glaucoma medications decreased from 2.0±1.4 to 0.8±1.0 (p<0.001) in the T-MT group and from 1.5±1.3 to 1.0±1.5 in the B-MT group (p=0.032). Similar improvements in visual acuity were observed in both groups. Complications were mild and resolved without intervention.

Conclusion: The tri-modal treatment is safe and may be more effective in reducing IOP and glaucoma medication requirements than bi-modal treatment.

Keywords: MIGS; glaucoma surgery; micro-incisional glaucoma surgery; trabecular meshwork.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest related to this work.

Figures

Figure 1
Figure 1
Ab interno goniotomy with a Kahook Dual Blade. (A) Visualization of angle structures with a surgical angle lens. (B) The KDB was engaged in the pigmented trabecular meshwork and then advanced at 120° parallel toward the wall of Schlemm’s canal. (C) Blood reflux in the angle at the end of the procedure.
Figure 2
Figure 2
Comparison of mean IOP over time in the T-MT and B-MT groups. The figure shows a reduction in IOP at every visit during the 12-month follow-up.
Figure 3
Figure 3
Comparison of number of glaucoma medications over time in the T-MT and B-MT groups. The figure shows a decrease in the number of glaucoma medications at every visit and during the 12-month follow-up.
Figure 4
Figure 4
Comparison of best-corrected visual acuity (BCVA) in both groups over time. The figure shows the changes in BCVA during the study period for both groups.

Similar articles

Cited by

References

    1. Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Global Health. 2017;5(12):e1221–1234. doi:10.1016/S2214-109X(17)30393-5 - DOI - PubMed
    1. Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121(11):2081–2090. doi:10.1016/j.ophtha.2014.05.013 - DOI - PubMed
    1. Tseng VL, Yu F, Lum F, Coleman AL. Risk of fractures following cataract surgery in medicare beneficiaries. JAMA. 2012;308(5). doi:10.1001/jama.2012.9014 - DOI - PubMed
    1. Sommer A. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore eye survey. Arch Ophthalmol. 1991;109(8):1090–1095. doi:10.1001/archopht.1991.01080080050026 - DOI - PubMed
    1. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–713. doi:10.1001/archopht.120.6.701 - DOI - PubMed

LinkOut - more resources